Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Stanford President’s Venture Fund is a venture capital vehicle managed by Stanford University that invests in early-stage companies founded by Stanford faculty, students, and alumni. The fund specifically targets high-impact startups emerging from the university's research ecosystem, with a significant portion of its portfolio dedicated to the life sciences, biotechnology, and healthcare sectors. By providing seed and early-stage capital, the fund aims to accelerate the translation of academic innovation into commercial products and services. It operates as part of Stanford's broader investment and technology transfer strategy, often co-investing alongside top-tier venture capital firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stanford President’s Venture Fund.